Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

Abstract. Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst developm

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gansevoort, Ron T. (VerfasserIn) , Arici, Mustafa (VerfasserIn) , Benzing, Thomas (VerfasserIn) , Birn, Henrik (VerfasserIn) , Capasso, Giovambattista (VerfasserIn) , Covic, Adrian (VerfasserIn) , Devuyst, Olivier (VerfasserIn) , Drechsler, Christiane (VerfasserIn) , Eckardt, Kai-Uwe (VerfasserIn) , Emma, Francesco (VerfasserIn) , Knebelmann, Bertrand (VerfasserIn) , Le Meur, Yannick (VerfasserIn) , Massy, Ziad A. (VerfasserIn) , Ong, Albert C. M. (VerfasserIn) , Ortiz, Alberto (VerfasserIn) , Schaefer, Franz (VerfasserIn) , Torra, Roser (VerfasserIn) , Vanholder, Raymond (VerfasserIn) , Więcek, Andrzej (VerfasserIn) , Zoccali, Carmine (VerfasserIn) , Van Biesen, Wim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 29 January 2016
In: Nephrology, dialysis, transplantation
Year: 2016, Jahrgang: 31, Heft: 3, Pages: 337-348
ISSN:1460-2385
DOI:10.1093/ndt/gfv456
Online-Zugang:Verlag, Volltext: https://doi.org/10.1093/ndt/gfv456
Verlag, Volltext: https://academic.oup.com/ndt/article/31/3/337/2460159
Volltext
Verfasserangaben:Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen

MARC

LEADER 00000caa a2200000 c 4500
001 1692282182
003 DE-627
005 20220818012040.0
007 cr uuu---uuuuu
008 200311s2016 xx |||||o 00| ||eng c
024 7 |a 10.1093/ndt/gfv456  |2 doi 
035 |a (DE-627)1692282182 
035 |a (DE-599)KXP1692282182 
035 |a (OCoLC)1341310197 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Gansevoort, Ron T.  |e VerfasserIn  |0 (DE-588)1206290706  |0 (DE-627)1692281933  |4 aut 
245 1 0 |a Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease  |b a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice  |c Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen 
264 1 |c 29 January 2016 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.03.2020 
520 |a Abstract. Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst developm 
700 1 |a Arici, Mustafa  |e VerfasserIn  |4 aut 
700 1 |a Benzing, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Birn, Henrik  |e VerfasserIn  |4 aut 
700 1 |a Capasso, Giovambattista  |e VerfasserIn  |4 aut 
700 1 |a Covic, Adrian  |e VerfasserIn  |4 aut 
700 1 |a Devuyst, Olivier  |e VerfasserIn  |4 aut 
700 1 |a Drechsler, Christiane  |e VerfasserIn  |4 aut 
700 1 |a Eckardt, Kai-Uwe  |e VerfasserIn  |4 aut 
700 1 |a Emma, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Knebelmann, Bertrand  |e VerfasserIn  |4 aut 
700 1 |a Le Meur, Yannick  |e VerfasserIn  |4 aut 
700 1 |a Massy, Ziad A.  |e VerfasserIn  |4 aut 
700 1 |a Ong, Albert C. M.  |e VerfasserIn  |4 aut 
700 1 |a Ortiz, Alberto  |e VerfasserIn  |4 aut 
700 1 |a Schaefer, Franz  |d 1961-  |e VerfasserIn  |0 (DE-588)1023365383  |0 (DE-627)718365577  |0 (DE-576)366705598  |4 aut 
700 1 |a Torra, Roser  |e VerfasserIn  |4 aut 
700 1 |a Vanholder, Raymond  |e VerfasserIn  |4 aut 
700 1 |a Więcek, Andrzej  |e VerfasserIn  |4 aut 
700 1 |a Zoccali, Carmine  |e VerfasserIn  |4 aut 
700 1 |a Van Biesen, Wim  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Nephrology, dialysis, transplantation  |d Oxford : Oxford Univ. Press, 1986  |g 31(2016), 3, Seite 337-348  |h Online-Ressource  |w (DE-627)265778395  |w (DE-600)1465709-0  |w (DE-576)079420079  |x 1460-2385  |7 nnas  |a Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice 
773 1 8 |g volume:31  |g year:2016  |g number:3  |g pages:337-348  |g extent:12  |a Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice 
856 4 0 |u https://doi.org/10.1093/ndt/gfv456  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://academic.oup.com/ndt/article/31/3/337/2460159  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20200311 
993 |a Article 
994 |a 2016 
998 |g 1023365383  |a Schaefer, Franz  |m 1023365383:Schaefer, Franz  |d 910000  |d 910500  |e 910000PS1023365383  |e 910500PS1023365383  |k 0/910000/  |k 1/910000/910500/  |p 16 
999 |a KXP-PPN1692282182  |e 3606523246 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1692282182","id":{"eki":["1692282182"],"doi":["10.1093/ndt/gfv456"]},"physDesc":[{"extent":"12 S."}],"language":["eng"],"relHost":[{"id":{"issn":["1460-2385"],"zdb":["1465709-0"],"eki":["265778395"]},"recId":"265778395","language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 01-04-14"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"pages":"337-348","extent":"12","issue":"3","volume":"31","year":"2016","text":"31(2016), 3, Seite 337-348"},"pubHistory":["1.1986 -"],"origin":[{"publisher":"Oxford Univ. Press","dateIssuedKey":"1986","dateIssuedDisp":"1986-","publisherPlace":"Oxford"}],"titleAlt":[{"title":"Nephrology, dialysis, transplantation online"}],"title":[{"title":"Nephrology, dialysis, transplantation","title_sort":"Nephrology, dialysis, transplantation"}],"disp":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best PracticeNephrology, dialysis, transplantation"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 11.03.2020"],"origin":[{"dateIssuedDisp":"29 January 2016","dateIssuedKey":"2016"}],"name":{"displayForm":["Ron T. Gansevoort, Mustafa Arici, Thomas Benzing, Henrik Birn, Giovambattista Capasso, Adrian Covic, Olivier Devuyst, Christiane Drechsler, Kai-Uwe Eckardt, Francesco Emma, Bertrand Knebelmann, Yannick Le Meur, Ziad A. Massy, Albert C. M. Ong, Alberto Ortiz, Franz Schaefer, Roser Torra, Raymond Vanholder, Andrzej Więcek, Carmine Zoccali and Wim Van Biesen"]},"title":[{"title_sort":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease","title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease","subtitle":"a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice"}],"person":[{"given":"Ron T.","display":"Gansevoort, Ron T.","role":"aut","roleDisplay":"VerfasserIn","family":"Gansevoort"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Arici","display":"Arici, Mustafa","given":"Mustafa"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Benzing","given":"Thomas","display":"Benzing, Thomas"},{"given":"Henrik","display":"Birn, Henrik","family":"Birn","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Giovambattista","display":"Capasso, Giovambattista","family":"Capasso","role":"aut","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Covic","display":"Covic, Adrian","given":"Adrian"},{"display":"Devuyst, Olivier","given":"Olivier","role":"aut","roleDisplay":"VerfasserIn","family":"Devuyst"},{"given":"Christiane","display":"Drechsler, Christiane","family":"Drechsler","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Eckardt","roleDisplay":"VerfasserIn","role":"aut","display":"Eckardt, Kai-Uwe","given":"Kai-Uwe"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Emma","display":"Emma, Francesco","given":"Francesco"},{"display":"Knebelmann, Bertrand","given":"Bertrand","role":"aut","roleDisplay":"VerfasserIn","family":"Knebelmann"},{"display":"Le Meur, Yannick","given":"Yannick","role":"aut","roleDisplay":"VerfasserIn","family":"Le Meur"},{"family":"Massy","roleDisplay":"VerfasserIn","role":"aut","display":"Massy, Ziad A.","given":"Ziad A."},{"family":"Ong","roleDisplay":"VerfasserIn","role":"aut","display":"Ong, Albert C. M.","given":"Albert C. M."},{"roleDisplay":"VerfasserIn","role":"aut","family":"Ortiz","given":"Alberto","display":"Ortiz, Alberto"},{"given":"Franz","display":"Schaefer, Franz","family":"Schaefer","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Roser","display":"Torra, Roser","role":"aut","roleDisplay":"VerfasserIn","family":"Torra"},{"family":"Vanholder","role":"aut","roleDisplay":"VerfasserIn","display":"Vanholder, Raymond","given":"Raymond"},{"given":"Andrzej","display":"Więcek, Andrzej","family":"Więcek","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Zoccali, Carmine","given":"Carmine","role":"aut","roleDisplay":"VerfasserIn","family":"Zoccali"},{"given":"Wim","display":"Van Biesen, Wim","family":"Van Biesen","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a GANSEVOORTRECOMMENDA2920